Top Selling Medicines


The text that follows is owned by the site above referred.

Here is only a small part of the article, for more please follow the link


The thyroid drug Synthroid continues to be the nation’s most-prescribed medication. But Humira, which treats a variety of conditions, had the highest sales, according to the research firm IMS Health.

The firm released data on the top 100 prescriptions and sales from April 2014 through March 2015.

Synthroid (levothyroxine), which treats hypothyroidism, or underactive thyroid disease, has been the top-prescribed medicine for several years.

Humira (adalimumab), which treats conditions including arthritis and Crohn’s disease, overtook last year’s best-seller, Abilify (aripiprazole).

The top 10 medications by number of monthly prescriptions are:

  1. Synthroid (levothyroxine), 21.5 million
  2. Crestor (rosuvastatin), 21.4 million
  3. Ventolin HFA (albuterol), 18.2 million
  4. Nexium (esomeprazole), 15.2 million
  5. Advair Diskus (fluticasone), 13.7 million
  6. Lantus Solostar (insulin glargine), 10.9 million
  7. Vyvanse (lisdexamfetamine), 10.4 million
  8. Lyrica (pregabalin), 10.0 million
  9. Spiriva Handihaler (tiotropium), 9.6 million
  10. Januvia (sitagliptin), 9.1 million

The top 10 meds by sales are:

  1. Humira (adalimumab), $8.2 billion
  2. Abilify (aripiprazole), $7.9 billion
  3. Sovaldi (sofosbuvir), $6.9 billion
  4. Crestor (rosuvastatin), $5.9 billion
  5. Enbrel (etanercept), $5.9 billion
  6. Harvoni (ledipasvir and sofosbuvir), $5.3 billion
  7. Nexium (esomeprazole), $5.3 billion
  8. Advair Diskus (fluticasone), $4.7 billion
  9. Lantus Solostar (insulin glargine), $4.7 billion
  10. Remicade (infliximab), $4.6 billion

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s